Scientists successfully awaken sleeping stem cells
... harm the retina, such as macular degeneration and retinitis pigmentosa. This study is very significant. ... the type of cells that are lost in retinitis pigmentosa or macular degeneration, as a result, ... have diseases that mimic macular degeneration and retinitis pigmentosa. The goal would be to learn if damaged ...Video: Turning Hope Into Reality - Vision Research at the VA
... retina to restore vision to those affected by macular degeneration and retinitis pigmentosa; the design and improvement of assistive devices for those with ... For those with this condition or another major cause of vision loss, retinitis pigmentosa, VA researchers in Atlanta are now working in the laboratory on ...Gene-Transfer Proves Safe for Vision Problem
... and is one of several incurable forms of blindness collectively known as retinitis pigmentosa, which in turn affects about 200,000 Americans. More information The Prevent Blindness America has more about retinitis pigmentosa . -- Kevin McKeever ...JCI online early table of contents: March 3, 2008
... GENETICS: Seeing clearly how genetic mutations cause loss of sight retinitis pigmentosa (RP) is a hereditary disease that often results in complete ... present in a cell. TITLE: Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay ...Developing gene therapy to fight blindness
... to develop gene therapy for treating a rare, hereditary retinal disease. The therapy has been shown to restore lost vision in animal models of retinitis pigmentosa (RP). Their work is being funded in part by a $1.5 million grant from the Prince Salman Center for Disability Research in Saudi Arabia, ...LSUHSC research identifies enzyme that makes survival molecule for key vision cells
... do not function properly, photoreceptor cells are damaged and can die, leading to decreased vision and eventual blindness as in such conditions as retinitis pigmentosa and age-related macular degeneration. A number of stressors, including free radicals, damage RPE cells. Dr. Bazan's lab has shown that RPE ...Principal Management Group Walks to Fight Blindness
... The Foundation Fighting Blindness, Inc. works to promote and encourage research that will provide all levels of assistance to individuals affected by retinitis pigmentosa, macular degeneration, Usher syndrome, and other retinal degenerative diseases. FFB currently funds over 115 research studies at 80 ...Ophthonix Completes Series AA Financing at $25.9 Million
... Mr. Gund is co-founder of The Foundation Fighting Blindness, a non for profit organization driving research to find causes, treatments and cures for retinitis pigmentosa, macular degeneration, Usher Syndrome, and other retinal degenerative diseases. Gund Investment Corporation is located at 14 Nassau ...June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates
... small print that can accompany aging. Low vision is caused by eye diseases such as macular degeneration, glaucoma, cataracts, diabetic retinopathy or retinitis pigmentosa. Vision loss can be mild to severe. Patients should work with a low-vision specialist to determine the best tools and how to use ...Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
... as well as clinical programs underway for such indications as allergic conjunctivitis, diabetic macular edema, retinal vein occlusion, and retinitis pigmentosa. To advance the development and commercialization of its programs, Fovea is working both independently and through collaborations ...Gene Therapy Provides Vision to People who Were Nearly Blind
... mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome, and the entire spectrum of retinal degenerative diseases. ...ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
... HIV-infected patients. Foscarnet, the main metabolite of ANX-201, is approved by the FDA for use in immunocompromised patients with CMV retinitis and mucocutaneous acyclovir-resistant HSV infections. However, clinical use of foscarnet is limited, in part due to its intravenous administration ...Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA Nanoparticles
... Copernicus' DNA nanoparticles corrected vision defects in a mouse model of retinitis pigmentosa (RP). These findings were presented at the American Society of ... that will provide preventions, treatments and cures for people affected by retinitis pigmentosa (RP), macular degeneration, Usher syndrome, and the entire ...Acquired Immunodeficiency Syndrome
... ( AIDS ), and cancer . Living in a warm, damp climate. Cytovene-IV (ganciclovir sodium for injection ) Indication: treatment of CMV retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome ( AIDS ); ... and formulas in China and Japan has ...Progression of retinal disease linked to cell starvation
... first step in vision. The incurable eye disease retinitis Pigmentosa, however, reveals a codependent ... "This is the first study linking cone death in retinitis Pigmentosa to a metabolic problem that suggests ... levels in the cones. Perhaps someday we can help retinitis Pigmentosa patients maintain their daylight ...Scientists eye secrets of retinal regeneration
... of disabling or blinding eye diseases such as retinitis pigmentosa," explains senior author Dr. Ching-Hwa ... trafficking were crucial to a common eye disease, retinitis pigmentosa." retinitis pigmentosa, a genetic disorder affecting about ...UCSF researchers identify new drug target for Kaposi's sarcoma
... the researchers said. Those include mononucleosis (Epstein-Barr virus), shingles (Varicella zoster virus), genital herpes (herpes simplex), retinitis (cytomegalovirus) and cancer (Kaposi's sarcoma). While therapies exist for these viruses, they often have negative side effects and are facing rising ...Work in mice will contribute to the study of hereditary diseases that lead to blindness
... consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse's retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world. In ...Case Western Reserve University receives $1.66m grant from NIH for otoprotection research
... in Ushers syndrome. Usher Syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by congenital deafness and retinitis pigmentosa. It is the most common cause of deafness accompanied by blindness. *There are about 10-15,000 people with Usher syndrome in the United ...Cats' eye diseases genetically linked to diseases in humans
... COLUMBIA, Mo. About one in 3,500 people are affected with retinitis pigmentosa (RP), a disease of the retina's visual cells that eventually leads to blindness. Now, a University of Missouri researcher has identified a ...Gene therapy restores vision to mice with retinal degeneration
... cells found throughout the retina. "This is a proof of principle that someday we may be able to repair blindness in people with conditions like retinitis pigmentosa and macular degeneration," says Richard Masland, PhD, director of the Cellular Neurobiology Laboratory in the MGH Department of ...Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
... of PDEs in vision may lead someday to better drug treatment for loss of eyesight from damaged retinas, such as occurs in night blindness and retinitis pigmentosa. ...New gene discovered for new form of intellectual disability
... Addiction and Mental Health (CAMH) has discovered a new form of intellectual disability involving mental retardation (MR) along with the eye defect retinitis pigmentosa (RP). CAMH also discovered the previously unidentified gene that causes this disorder, CC2D2A. This scientific advance will help ...RNA interference therapy heals growth deficiency disorder in a live animal
... Some other common dominant negative diseases include forms of colon cancer, deafness, muscular dystrophy, brittle bone disease, kidney disease and retinitis pigmentosa. The blueprint for a protein like growth hormone is genetically encoded in a series of special segments called exons. The instructions in ...Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
... Clinical Programs: Phase 2/3 Studies in retinitis Pigmentosa (RP) Neurotech is conducting two ... endpoint of this study. About the Diseases retinitis Pigmentosa (RP) is an inherited disease that ... in late-stage clinical development for retinitis pigmentosa (RP) and dry age-related macular ...OpenClinica EDC Solution Deployed for Retina Implant Studies
... used as a hearing prosthesis. The device will primarily be used to treat retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD). ... restore sight to people who have a degenerative retinal disease such as retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD). For more ...R-Tech Ueno Notifies R&D Items
... that is marketed as a therapeutic drug for glaucoma and ocular hypertension. This drug is now being developed by R-Tech Ueno for the indication of retinitis pigmentosa. The drug is introduced to Sucampo Pharma Americas Ltd. in the USA to be developed for the indication of atrophic age-related macular ...Discovery of a new retinal gene involved in childhood blindness
... played a crucial role in the international collaboration that led to the discovery of a new gene that causes Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP), two devastating forms of childhood blindness. This finding of this new gene, called SPATA7, is remarkable because it identifies a ...Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
... offering a significant opportunity in the future. Valganciclovir HCl Tablets are indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valganciclovir HCl is also indicated for the prevention of cytomegalovirus (CMV) disease ...USC and second sight announce European clinical trial for Argus II retinal implant
... systems at home daily. The Argus II is the second generation of an electronic retinal implant designed for the treatment of blindness due to retinitis Pigmentosa (RP), a group of inherited eye diseases that affect the retina. The Argus II implant consists of an array of 60 electrodes that are ...Fovea Pharmaceuticals Completes EUR30M Series B Financing
... (neuroprotection), retinal dystrophies as well as clinical programs underway for such indications as macular edema, allergic conjunctivitis, or retinitis pigmentosa. To advance the development and commercialization of its programs, FOVEA is working both independently and through collaborators ...